Is TheraSphere FDA approved?
FDA Approves TheraSphere Y-90 Glass Microspheres for Unresectable Hepatocellular Carcinoma. Today, the U.S. Food and Drug Administration (FDA) approved TheraSphere Y-90 Glass Microspheres, developed for the treatment of patients with hepatocellular carcinoma.
Is TheraSphere a medical device?
TheraSphere is a medical device containing yttrium-90 (Y-90), a radioactive material that has been used previously in the treatment of liver tumors.
What is Y90 used for?
Radioembolization is a minimally invasive procedure that combines embolization and radiation therapy to treat liver cancer. Tiny glass or resin beads filled with the radioactive isotope yttrium Y-90 are placed inside the blood vessels that feed a tumor.
Can Radioembolization cure liver cancer?
Radioembolization is a minimally invasive treatment that provides relief from symptoms but does not provide a cure for liver cancer. As with any treatment, there are risks and side effects; however, extensive measures are put in place before the procedure is done to limit the incidence of complications.
How much does y90 treatment cost?
The primary outcome was the overall difference in cost between Y-90 vs TACE for treatment of hepatocellular carcinoma at Einstein Medical Center. The price of a Y-90 ranges from $30,000 to $35,000 with an average of $32,500. The price of a TACE ranges from $18,000 to $22,000 with an average of $20,000.
When was y90 FDA approved?
MARLBOROUGH, Mass., March 18, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval of the TheraSphere™ Y-90 Glass Microspheres, developed for the treatment of patients with hepatocellular carcinoma (HCC).
What cancers does yttrium-90 Treat?
Yttrium-90 internal radiation therapy is a treatment for some inoperable cancers….Cancers We Treat With Yttrium-90 Internal Radiation Therapy
- Liver Cancer.
- Metastatic Colon Cancer.
- Neuroendocrine Tumors.
What are the side effects of Y-90 treatment?
Most patients have some side effects after the Y-90 treatment. These include pain, nausea, a low-grade fever, or chills. This is called post- embolization syndrome. You may have fevers for up to 1 week.
Who is a candidate for Y90?
When is Y90 therapy indicated? Hepatic (liver) tumors (lesions or masses) may originate as a primary cancer of the liver such as hepatocellular cancer (90% of primary liver cancers) or may be another form of cancer that has metastasized to the region.
How many times can you get Y90?
Patients are typically limited to two treatments, although doctors can take another approach — only with concentrated chemotherapy and larger particles — once radiation limits are reached. “He could potentially have that multiple times to prolong his survival and keep him doing well,” Dr.
How many times can you have Y-90 treatments?
What are the side effects of Y-90?
What are the side effects of Y90?
Who is a candidate for Y-90?
How successful is Y90 treatment?
In contrast to most nuclear medicine applications, Y90 is therapeutic and designed to treat rather than simply diagnose. It is estimated that 75% to 95% of patients see improvement from treatment, potentially extending their lives or improving survival rates.